Fitness & Wearable Tech — August 3, 2026
This week brought fresh momentum to the wearable smartwatch market with expert reviews highlighting the newest generation devices, while Strava advanced its strength training capabilities and the FDA's relaxed guidance continues reshaping how blood pressure and glucose monitoring reach consumers through non-invasive wearable technology.
Fitness & Wearable Tech — August 3, 2026
Wearable Hardware
Samsung Galaxy Watch Ultra 2 & Galaxy Watch 9
- Brand: Samsung
- What's new: Larger batteries, more power-efficient Qualcomm chip, new health metrics
- Why it matters: Samsung's latest flagships offer extended battery life and expanded health monitoring capabilities, though with notable price increases. The devices represent significant hardware evolution in the ultra-competitive premium smartwatch segment.
Google Pixel Watch 4
- Brand: Google
- What's new: Hardware improvements over its predecessor; strongest fitness smartwatch for Android users
- Why it matters: The Pixel Watch 4 signals Google's commitment to competitive wearable hardware development, offering Android users a first-party flagship alternative to Apple Watch and Samsung.
2026 Flagship Smartwatch Reviews
- What's new: ZDNET, Trusted Reviews, CNET, Runners' World, and other major tech outlets released comprehensive tested reviews of 2026's leading smartwatches and fitness trackers
- Why it matters: Expert hands-on testing validates feature claims and helps consumers navigate a crowded market with genuine performance data across running, cycling, swimming, and general health monitoring.
Apps & Platforms
Strava Strength Training Feature Upgrade
- Update: Strava completed an overhaul of its strength training capabilities, allowing users to track exercises, sets, reps, weight, and muscle maps in detail. The update integrates partner app connections for seamless workout logging.
- Who benefits: Gym-goers and athletes who use Strava for resistance training alongside cardio—now they can consolidate all fitness activity types on a single platform.
Strava Apple Watch App Support
- Update: Strava confirmed native Apple Watch app compatibility with watchOS 10.0+ and iOS 17.0+, enabling automatic companion app installation on users' watches.
- Who benefits: iPhone and Apple Watch users who want native wearable support for logging runs, rides, and workouts without relying on phone syncing.
Strava Fitness Scoring System
- Update: Strava's Fitness score now tracks athlete progress based on Relative Effort and power data, helping users identify training patterns and improvements over time.
- Who benefits: Serious cyclists and runners using power meters who want data-driven insights into training consistency and fitness trajectory.
Health Sensing & Research
- Wearable Health Tech Innovations 2026: Non-invasive multimodal sensors, on-device AI processing, and FDA-cleared pathways for cuffless blood pressure monitoring are reshaping the clinical validation landscape. These advances enable real-time health insights without traditional invasive methods.
- FDA Guidance on Blood Pressure Wearables: New FDA guidance clarifies that non-invasive photoplethysmogram-based blood pressure estimation in wearables (including devices from Oura and Samsung) can qualify as general wellness products. This deregulation has opened the market to multiple manufacturers, though experts note the need for consumer awareness about device limitations versus clinical-grade monitors.
Weekly Analysis
The wearable market in early August 2026 reflects a maturing ecosystem where hardware differentiation increasingly centers on battery longevity and sensor depth, while software platforms like Strava strengthen their role as central hubs for multi-activity tracking. Samsung's pricing strategy on the Galaxy Watch Ultra 2 signals confidence in premium positioning despite competition from Google and Apple, while Strava's strength training overhaul and Apple Watch integration address a gap that previously fragmented gym-focused users across multiple apps. Simultaneously, the FDA's relaxed guidance on blood pressure and glucose wearables has flooded the market with new devices, creating both opportunity and confusion—consumers now benefit from choice but must carefully evaluate clinical validity versus wellness claims. The convergence of better on-device AI, multi-modal sensors, and regulatory clarity positions 2026 as a pivotal year where wearables transition from activity trackers to more holistic health monitors.
What to Watch Next Week
- FDA Regulatory Updates: Watch for any new FDA guidance on glucose monitoring wearables or other emerging biometric sensing categories, which could open or constrain manufacturer innovation pathways.
- App Integration Announcements: Major fitness platforms may announce partnerships with health systems or insurance providers, signaling deeper clinical adoption of consumer wearables.
Note: This week's coverage focused on expert device reviews, Strava's platform updates, and the continuing impact of FDA deregulation on health sensing capabilities. Limited breaking product launches appeared in the past 7 days; most 2026 major releases occurred in July. Check back next week for potential new hardware announcements and firmware rollouts.
This content was collected, curated, and summarized entirely by AI — including how and what to gather. It may contain inaccuracies. Crew does not guarantee the accuracy of any information presented here. Always verify facts on your own before acting on them. Crew assumes no legal liability for any consequences arising from reliance on this content.
Powered by
